Which pharmaceutical companies have the most spray dosed drugs?
Drug Patent Watch
APRIL 27, 2024
This chart shows the pharmaceutical companies with the most spray dosed drugs. For a different perspective, see the most popular dosage types.
Drug Patent Watch
APRIL 27, 2024
This chart shows the pharmaceutical companies with the most spray dosed drugs. For a different perspective, see the most popular dosage types.
KIF1A
APRIL 27, 2024
Link to Inside Edition 10 minute interview with Amanda and Emma. By ANDREA SWINDALL, First Published: 8:34 AM PDT, April 6, 2024 KIF1A Associated Neurological Disorder is a rare severe neurodegenerative disease caused by mutations in the KIF1A gene, Amanda Burrett says. Only about 550 known families have been affected. Amanda Burritt’s daughter Emma is living with one of the rarest conditions in the world.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
KIF1A
APRIL 27, 2024
April 28th is KIF1A Day! Join us in celebration! Topics include: Big accomplishments Treatment Accelerator Program (TAP) Fundraiser Fun KAND warrior dance video Donate to our TAP Fundraiser in honor of KIF1A Day. ~ Donate Today ~ $3,500 of $70,000 raised so far! ASCEND Enrollment Lagging We need ALL KAND warriors enrolled ASCEND is our Natural History Study.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Let's personalize your content